Affinity Asset Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100,049
| Closed | -$5.88M | – | 112 |
|
|
2023
Q4 | $5.88M | Buy |
100,049
+39,623
| +66% | +$2.33M | 1.07% | 25 |
|
|
2023
Q3 | $2.63M | Buy |
+60,426
| New | +$2.63M | 0.74% | 34 |
|
|
2022
Q1 | – | Sell |
-20,000
| Closed | -$2.93M | – | 72 |
|
|
2021
Q4 | $2.93M | Sell |
20,000
-7,500
| -27% | -$1.1M | 1.07% | 32 |
|
|
2021
Q3 | $4.87M | Buy |
+27,500
| New | +$4.87M | 1.23% | 17 |
|
|
2021
Q1 | – | Sell |
-10,000
| Closed | -$2.2M | – | 79 |
|
|
2020
Q4 | $2.2M | Buy |
+10,000
| New | +$2.2M | 1.16% | 23 |
|